UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Risk factors for lymph node metastases in women with endometrial cancer: A population‐based, nation‐wide register study—On behalf of the Swedish Gynecological Cancer Group

International journal of cancer, 2017-06, Vol.140 (12), p.2693-2700

2017

Volltextzugriff (PDF)

Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study

Acta oncologica, 2019-11, Vol.58 (11), p.1628-1633

2019

Volltextzugriff (PDF)

Preoperative and intraoperative assessment of myometrial invasion in endometrial cancer—A Swedish Gynecologic Cancer Group (SweGCG) study

Acta obstetricia et gynecologica Scandinavica, 2021-08, Vol.100 (8), p.1526-1533

2021

Volltextzugriff (PDF)

Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12

Gynecologic oncology, 2019-02, Vol.152 (2), p.235-242

2019

Volltextzugriff (PDF)

Primary treatment and relative survival by stage and age in vulvar squamous cell carcinoma: A population-based SweGCG study

Gynecologic oncology, 2020-12, Vol.159 (3), p.663-671

2020

Volltextzugriff (PDF)

Lymphedema and bladder‐emptying difficulties after radical hysterectomy for early cervical cancer and among population controls

International journal of gynecological cancer, 2006-05, Vol.16 (3), p.1130-1139

2006

Volltextzugriff (PDF)

Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG)

Gynecologic oncology, 2017-01, Vol.144 (1), p.167-173

2017

Volltextzugriff (PDF)

Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG symptom benefit study (SBS)

Gynecologic oncology, 2020-01, Vol.156 (1), p.45-53

2020

Volltextzugriff (PDF)

Psychological health in patients with genital and oral erosive lichen planus

Journal of the European Academy of Dermatology and Venereology, 2006-07, Vol.20 (6), p.661-666

2006

Volltextzugriff (PDF)

Patient-rating of distressful symptoms after treatment for early cervical cancer

Acta obstetricia et gynecologica Scandinavica, 2002-05, Vol.81 (5), p.443-450

2002

Volltextzugriff (PDF)

Patterns of recurrence and survival in vulvar cancer: A nationwide population-based study

Gynecologic oncology, 2021-06, Vol.161 (3), p.748-754

2021

Volltextzugriff (PDF)

PUVA and cancer risk: the Swedish follow-up study

British journal of dermatology (1951), 1999-07, Vol.141 (1), p.108-112

1999

Volltextzugriff (PDF)

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer

The New England journal of medicine, 2021-12, Vol.385 (23), p.2123-2131

2021

Volltextzugriff (PDF)

Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse

Journal of clinical oncology, 2010-07, Vol.28 (20), p.3323-3329

2010

Volltextzugriff (PDF)

Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic lymphadenectomy in women with high-risk endometrial cancer: A randomised controlled trial

European journal of cancer (1990), 2017-07, Vol.79, p.81-89

2017

Volltextzugriff (PDF)

Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy

Journal of medical genetics, 2013-09, Vol.50 (9), p.599-605

2013

Volltextzugriff (PDF)

Lower limb lymphedema in gynecological cancer survivors—effect on daily life functioning

Supportive care in cancer, 2013-11, Vol.21 (11), p.3063-3070

2013

Volltextzugriff (PDF)

High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer

Gynecologic oncology, 2020-12, Vol.159 (3), p.860-868

2020

Volltextzugriff (PDF)

Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer—The GCIG Symptom Benefit Study

The oncologist (Dayton, Ohio), 2017-09, Vol.22 (9), p.1117-1124

2017

Volltextzugriff (PDF)

Synergy Between Sexual Abuse and Cervical Cancer in Causing Sexual Dysfunction

Journal of sex & marital therapy, 2005-10, Vol.31 (5), p.361-383

2005

Volltextzugriff (PDF)

Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer

Journal of clinical oncology, 2010-09, Vol.28 (27), p.4162-4169

2010

Volltextzugriff (PDF)

Lymphedema, serious adverse events, and imaging 1 year after comprehensive staging for endometrial cancer: results from the RASHEC trial

International journal of gynecological cancer, 2019-01, Vol.29 (1), p.86-93

2019

Volltextzugriff (PDF)

Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease - a Swedish Gynecologic Cancer Group (SweGCG) study

Acta oncologica, 2018-01, Vol.57 (3), p.331-337

2018

Volltextzugriff (PDF)

Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival

Oncotarget, 2016-04, Vol.7 (14), p.18573-18584

2016

Volltextzugriff (PDF)

HSP60 Predicts Survival in Advanced Serous Ovarian Cancer

International journal of gynecological cancer, 2013-03, Vol.23 (3), p.448-455

2013

Volltextzugriff (PDF)

1 – 25 von 148

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(124)

Publikationsform

Artikel
(148)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Risk factors for lymph node metastases in women with endometrial cancer: A population‐based, nation‐wide register study—On behalf of the Swedish Gynecological Cancer Group

Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study

Preoperative and intraoperative assessment of myometrial invasion in endometrial cancer—A Swedish Gynecologic Cancer Group (SweGCG) study

Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12

Primary treatment and relative survival by stage and age in vulvar squamous cell carcinoma: A population-based SweGCG study

Lymphedema and bladder‐emptying difficulties after radical hysterectomy for early cervical cancer and among population controls

Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG)

Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG symptom benefit study (SBS)

Psychological health in patients with genital and oral erosive lichen planus

Patient-rating of distressful symptoms after treatment for early cervical cancer

Patterns of recurrence and survival in vulvar cancer: A nationwide population-based study

PUVA and cancer risk: the Swedish follow-up study

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer

Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse

Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic lymphadenectomy in women with high-risk endometrial cancer: A randomised controlled trial

Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy

Lower limb lymphedema in gynecological cancer survivors—effect on daily life functioning

High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer

Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer—The GCIG Symptom Benefit Study

Synergy Between Sexual Abuse and Cervical Cancer in Causing Sexual Dysfunction

Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer

Lymphedema, serious adverse events, and imaging 1 year after comprehensive staging for endometrial cancer: results from the RASHEC trial

Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease - a Swedish Gynecologic Cancer Group (SweGCG) study

Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival

HSP60 Predicts Survival in Advanced Serous Ovarian Cancer

Aktive Filter

Suchergebnisse filtern